LA MAISON DES DOCTEURS: what changed
What changed
LA MAISON DES DOCTEURS
NACE 86.220, Specialist medical practice
filed annual accounts (NBB)
Net result for the year
€65,304
2024 · €51,634+€13,670
Equity
€151,606
2024 · €145,126+€6,481
Cash
€135,490
2024 · €124,956+€10,534
Balance sheet total
€162,432
2024 · €152,871+€9,561
Largest movements
Assets
- Cash +€10,534
up €10,534 (+8.4%), from €124,956 to €135,490
mainly Net result for the year (+€65,304) and Depreciation (+€4,899)
- Receivables within one year -€3,427
down €3,427 (-21.8%), from €15,737 to €12,310
- Deferred charges and accrued income +€1,739
new in 2025: €1,739
Equity and liabilities
- Profit (loss) carried forward +€6,481
up €6,481 (+4.6%), from €140,126 to €146,606
- Other debts +€3,881
up €3,881 (+762%), from €509 to €4,390
Income statement
- Gross operating margin +€17,701
up €17,701 (+23.7%), from €74,556 to €92,257
- Taxes +€3,471
up €3,471 (+23.8%), from €14,610 to €18,081
- Depreciation +€1,502
up €1,502 (+44.2%), from €3,397 to €4,899
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€51,634
Gross operating margin
+€17,701
Depreciation
-€1,502
Other operating charges
-€184
Financial income
+€800
Financial charges
+€326
Taxes
-€3,471
Result 2025
€65,304
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€74,971
Investment
-€5,613
Financing
-€58,824
Cash 2024
€124,956
From operations (derived)
+€74,971
Net result for the year
+€65,304
Depreciation
+€4,899
Receivables within one year
+€3,427
Deferred charges and accrued income
-€1,739
Trade debts
-€495
Tax, wage and social debts
-€305
Other debts
+€3,881
Investment (derived)
-€5,613
Investment in fixed assets (net)
-€5,613
Financing
-€58,824
Contributions, distributions and other
-€58,824
Cash 2025
€135,490
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €152,871 | €162,432 | +€9,561 | +6.3% |
| Formation expenses | 20 | €761 | €0 | -€761 | -100% |
| Fixed assets | 21/28 | €11,418 | €12,893 | +€1,475 | +12.9% |
| Tangible fixed assets | 22/27 | €11,418 | €12,893 | +€1,475 | +12.9% |
| Plant, machinery and equipment | 23 | €2,969 | €2,180 | -€789 | -26.6% |
| Other tangible fixed assets | 26 | €8,449 | €10,713 | +€2,265 | +26.8% |
| Current assets | 29/58 | €140,693 | €149,539 | +€8,846 | +6.3% |
| Amounts receivable within one year | 40/41 | €15,737 | €12,310 | -€3,427 | -21.8% |
| Other amounts receivable | 41 | €15,737 | €12,310 | -€3,427 | -21.8% |
| Cash at bank and in hand | 54/58 | €124,956 | €135,490 | +€10,534 | +8.4% |
| Deferred charges and accrued income | 490/1 | - | €1,739 | +€1,739 | |
| Total equity and liabilities | 10/49 | €152,871 | €162,432 | +€9,561 | +6.3% |
| Equity | 10/15 | €145,126 | €151,606 | +€6,481 | +4.5% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €140,126 | €146,606 | +€6,481 | +4.6% |
| Amounts payable | 17/49 | €7,745 | €10,826 | +€3,080 | +39.8% |
| Amounts payable within one year | 42/48 | €7,745 | €10,826 | +€3,080 | +39.8% |
| Trade debts | 44 | €495 | €0 | -€495 | -100% |
| Suppliers | 440/4 | €495 | €0 | -€495 | -100% |
| Taxes, remuneration and social security | 45 | €6,741 | €6,435 | -€305 | -4.5% |
| Taxes | 450/3 | €6,741 | €6,435 | -€305 | -4.5% |
| Other amounts payable | 47/48 | €509 | €4,390 | +€3,881 | +762% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €3,397 | €4,899 | +€1,502 | +44.2% |
| Other operating charges | 640/8 | €691 | €875 | +€184 | +26.6% |
| Gross operating margin | 9900 | €74,556 | €92,257 | +€17,701 | +23.7% |
| Operating profit (loss) | 9901 | €70,468 | €86,483 | +€16,015 | +22.7% |
| Financial income | 75/76B | €210 | €1,010 | +€800 | +381% |
| Recurring financial income | 75 | €210 | €1,010 | +€800 | +381% |
| Financial charges | 65/66B | €4,434 | €4,108 | -€326 | -7.3% |
| Recurring financial charges | 65 | €4,434 | €4,108 | -€326 | -7.3% |
| Profit (loss) for the period before taxes | 9903 | €66,244 | €83,385 | +€17,141 | +25.9% |
| Income taxes | 67/77 | €14,610 | €18,081 | +€3,471 | +23.8% |
| Profit (loss) for the period | 9904 | €51,634 | €65,304 | +€13,670 | +26.5% |
| Profit (loss) for the period to be appropriated | 9905 | €51,634 | €65,304 | +€13,670 | +26.5% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.